Jeffrey Mason Chambliss, MD
Pediatric Allergist
Assistant Professor at UT Southwestern Medical Center
- Languages Spoken:
- English
Biography
Jeffrey Mason Chambliss, M.D., is a pediatric allergist at Children's Health℠ and an Assistant Professor at UT Southwestern Medical Center. He is certified by the American Board of Pediatrics and the American Board of Allergy and Immunology.
Dr. Chambliss’ research interests include immunotherapy and other emerging therapies for asthma.
Dr. Chambliss earned his medical degree at the University of Texas Health Science Center at San Antonio. He completed a residency in pediatrics at the University of North Carolina at Chapel Hill and a fellowship in allergy and immunology at the University of Texas Medical Branch Hospitals.
He is a member of the American Academy of Pediatrics; the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; the Texas Allergy, Asthma and Immunology Society; the Texas Medical Association; and the Dallas County Medical Society.
Dr. Chambliss was named a Texas Super Doctors Rising Star by Texas Monthly in 2022.
Education and Training
- Medical School
- University of Texas HSC at San Antonio (2013)
- Residency
- University of North Carolina Healthcare (2016), Pediatrics
- Fellowship
- University of Texas Medical Branch - Galveston (2018), Allergy/Immunology
- Board Certification
- American Board of Allergy and Immunology
Conditions
Departments and Programs
-
Research Interests
- Allergen immunotherapy
- Emerging therapies for asthma
- Urticaria
-
Publications
- A Polymorphism in the Catalase Gene Promoter Confers Protection against Severe RSV Bronchiolitis. Chambliss JM, Ansar M, Kelley JP, Spratt H, Garofalo RP, Casola A, Viruses 2020 01 12 1
- IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy. Dreskin SC, Germinaro M, Reinhold D, Chen X, Vickery BP, Kulis M, Burks AW, Negi SS, Braun W, Chambliss JM, Eglite S, McNulty CMG, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2019 12 30 8 817-823
- Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5. Chambliss JM, Sur S, Tripple JW Current opinion in allergy and clinical immunology 2018 Feb 18 1 26-31
- Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5. Chambliss JM, Sur S, Tripple JW Current opinion in allergy and clinical immunology 2018 Feb 18 1 26-31
- Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract. Patel HD, Chambliss JM, Gupta MR Current allergy and asthma reports 2017 Aug 17 9 63.
- Pharmacologic options for the treatment and management of food allergy. Kobernick AK, Chambliss J, Burks AW Expert review of clinical pharmacology 2015 8 5 623-33.
- Acute Hemorrhagic Edema of Infancy after Coronavirus Infection with Recurrent Rash. Chesser H, Chambliss JM, Zwemer E Case reports in pediatrics 2017 2017 5637503
- The latest on food allergy immunotherapy. Chambliss JM, Burks AW Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2016 Nov 117 5 476-478
-
Professional Activities
- American Academy of Pediatrics
- American Academy of Allergy, Asthma & Immunology
- American College of Allergy, Asthma & Immunology
- Dallas County Medical Society
- Texas Allergy, Asthma and Immunology Society
- Texas Medical Association
-
Awards and Honors
- Texas Super Doctors Rising Star (2022), Texas Monthly
- Outstanding Fellow Nominee (2018), UT Medical Branch at Galveston
- Excellence in Research, 2nd Place (2018), Texas Medical Center McGovern School of Medicine, 7th Annual Department of Pediatrics Fellows Research Symposium
- Travel Grant (2016-2018), American Academy of Allergy, Asthma and Immunology